Abstract
Chronic mild stress (CMS) has been demonstrated to contribute to atherosclerosis. 6-gingerol (6-Gin), a phenolic component of ginger (Zingiber officinale), has been shown to exert numerous pharmacological properties, such as anti-inflammatory and cardioprotective effects. Here we investigated the role of CMS in the development of atherosclerosis in high-fat diet (HFD)-fed ApoE−/− mice and evaluated the potential therapeutic effects of 6-Gin. Mice were exposed to CMS for 20 weeks, at week 5, they were fed with a high-fat diet (HFD), then received 6-Gin (20 mg/kg/day, intragastrically) treatment. Antiatherosclerotic simvastatin (Sim) and antidepressant lorazepam (Lor) were used for positive drugs. The behavioral and atherosclerotic changes, plasma lipid profiles as well as inflammatory cytokine levels were measured. Our results showed that CMS-exposed mice exhibited reduced body weight gain, sucrose preference and locomotor activity, which are representative of some of the core symptoms of depression. Furthermore, CMS challenge aggravated atherosclerotic lesions, as indicated by increased plaque formation, elevation of plasma total cholesterol, triglyceride, low-density lipoprotein cholesterin, and proinflammatory cytokines including TNF-α, IL-1β, and IL-6. In addition, the expression levels of phosphorylated adenosine monophosphate-activated protein kinase (p-AMPK), acetyl-CoA carboxylase (ACC), hHMG-CoA reductase (HMGCR), fatty acid synthase (FAS), sterol regulatory element binding protein (SREBP)-1 and SREBP-2 in the liver tissues were altered after CMS exposure. 6-Gin not only improved the behavioral changes, but also alleviated atherosclerotic lesions, and reversed the expression levels of lipid profiles and inflammatory cytokines in stressed mice. Moreover, the antiatherosclerotic effects of 6-Gin is mediated in part by the AMPK signaling pathway, which is closely associated with cholesterol synthesis and lipid accumulation. Together, these results suggest that 6-Gin attenuates arteriosclerosis in ApoE−/− mice exposed to CMS and HFD, and it may be a potential therapeutic agent for the treatment of atherosclerosis.
Similar content being viewed by others
References
Manduteanu, I., & Simionescu, M. (2012). Inflammation in atherosclerosis: A cause or a result of vascular disorders? Journal of Cellular and Molecular Medicine, 16(9), 1978–1990. https://doi.org/10.1111/j.1582-4934.2012.01552.x.
Libby, P. (2002). Inflammation in atherosclerosis. Nature, 420(6917), 868–874. https://doi.org/10.1038/nature01323.
Lusis, A. J. (2000). Atherosclerosis. Nature, 407(6801), 233–241. https://doi.org/10.1038/35025203.
Hansson, G. K. (2005). Inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine, 352(16), 1685–1695. https://doi.org/10.1056/NEJMra043430.
Fruchart, J. C., Nierman, M. C., Stroes, E. S., Kastelein, J. J., & Duriez, P. (2004). New risk factors for atherosclerosis and patient risk assessment. Circulation, 109(23), 15–19. https://doi.org/10.1161/01.cir.0000131513.33892.5b.
Steptoe, A., & Kivimaki, M. (2012). Stress and cardiovascular disease. Nature Reviews Cardiology, 9(6), 360–370. https://doi.org/10.1038/nrcardio.2012.45.
Ranjit, N., Diez-Roux, A. V., Shea, S., Cushman, M., Seeman, T., Jackson, S. A., et al. (2007). Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Archives of Internal Medicine, 167(2), 174–181. https://doi.org/10.1001/archinte.167.2.174.
Wang, S., Xiaoling, G., Pingting, L., Shuqiang, L., & Yuaner, Z. (2014). Chronic unpredictable mild stress combined with a high-fat diets aggravates atherosclerosis in rats. Lipids in Health and Disease, 13, 77. https://doi.org/10.1186/1476-511X-13-77.
Gu, H., Tang, C., Peng, K., Sun, H., & Yang, Y. (2009). Effects of chronic mild stress on the development of atherosclerosis and expression of toll-like receptor 4 signaling pathway in adolescent apolipoprotein E knockout mice. Journal of Biomedicine and Biotechnology, 2009, 613879. https://doi.org/10.1155/2009/613879.
Kumari, M., Grahame-Clarke, C., Shanks, N., Marmot, M., Lightman, S., & Vallance, P. (2003). Chronic stress accelerates atherosclerosis in the apolipoprotein E deficient mouse. Stress, 6(4), 297–299. https://doi.org/10.1080/10253890310001619461.
Sultan, M. T. (2011). Ginger and its health claims: molecular aspects. Critical Reviews in Food Science and Nutrition, 51(5), 383.
Kubra, I. R., & Rao, L. J. (2012). An impression on current developments in the technology, chemistry, and biological activities of ginger (Zingiber officinale Roscoe). Critical Reviews in Food Science and Nutrition, 52(8), 651.
Ho, S. C., Chang, K. S., & Lin, C. C. (2013). Anti-neuroinflammatory capacity of fresh ginger is attributed mainly to 10-gingerol. Food Chemistry, 141(3), 3183–3191. https://doi.org/10.1016/j.foodchem.2013.06.010.
Ajayi, B. O., Adedara, I. A., & Farombi, E. O. (2015). Pharmacological activity of 6-gingerol in dextran sulphate sodium-induced ulcerative colitis in BALB/c mice. Phytotherapy Research: PTR, 29(4), 566–572. https://doi.org/10.1002/ptr.5286.
Gundala, S. R., Mukkavilli, R., Yang, C., Yadav, P., Tandon, V., Vangala, S., et al. (2014). Enterohepatic recirculation of bioactive ginger phytochemicals is associated with enhanced tumor growth-inhibitory activity of ginger extract. Carcinogenesis, 35(6), 1320–1329. https://doi.org/10.1093/carcin/bgu011.
Srinivasan, K. (2014). Antioxidant potential of spices and their active constituents. Critical Reviews in Food Science and Nutrition, 54(3), 352–372. https://doi.org/10.1080/10408398.2011.585525.
Liu, Q., Liu, J., Guo, H., Sun, S., Wang, S., Zhang, Y., et al. (2013). 6-gingerol: A novel AT(1) antagonist for the treatment of cardiovascular disease. Planta Medica, 79(5), 322–326. https://doi.org/10.1055/s-0032-1328262.
El-Bassossy, H. M., Elberry, A. A., Ghareib, S. A., Azhar, A., Banjar, Z. M., & Watson, M. L. (2016). Cardioprotection by 6-gingerol in diabetic rats. Biochemical and Biophysical Research Communications, 477(4), 908–914. https://doi.org/10.1016/j.bbrc.2016.06.157.
Ghareib, S. A., El-Bassossy, H. M., Elberry, A. A., Azhar, A., Watson, M. L., & Banjar, Z. M. (2015). 6-Gingerol alleviates exaggerated vasoconstriction in diabetic rat aorta through direct vasodilation and nitric oxide generation. Drug Design, Development and Therapy, 9, 6019–6026. https://doi.org/10.2147/DDDT.S94346.
Okamoto, M., Irii, H., Tahara, Y., Ishii, H., Hirao, A., Udagawa, H., et al. (2011). Synthesis of a new [6]-gingerol analogue and its protective effect with respect to the development of metabolic syndrome in mice fed a high-fat diet. Journal of Medicinal Chemistry, 54(18), 6295–6304. https://doi.org/10.1021/jm200662c.
Tang, Y. L., Jiang, J. H., Wang, S., Liu, Z., Tang, X. Q., Peng, J., et al. (2015). TLR4/NF-kappaB signaling contributes to chronic unpredictable mild stress-induced atherosclerosis in ApoE−/− mice. PLoS ONE, 10(4), e0123685. https://doi.org/10.1371/journal.pone.0123685.
Yalcin, I., Aksu, F., & Belzung, C. (2005). Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol. European Journal of Pharmacology, 514(2–3), 165–174. https://doi.org/10.1016/j.ejphar.2005.03.029.
Ismail, B., Aboul-Fotouh, S., Mansour, A. A., Shehata, H. H., Salman, M. I., Ibrahim, E. A., et al. (2014). Behavioural, metabolic, and endothelial effects of the TNF-alpha suppressor thalidomide on rats subjected to chronic mild stress and fed an atherogenic diet. Canadian Journal of Physiology and Pharmacology, 92(5), 375–385. https://doi.org/10.1139/cjpp-2013-0446.
Jacobi, J., Maas, R., Cardounel, A. J., Arend, M., Pope, A. J., Cordasic, N., et al. (2010). Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine. The American Journal of Pathology, 176(5), 2559–2570. https://doi.org/10.2353/ajpath.2010.090614.
Zhou, L., Zheng, Y., Li, Z., Bao, L., Dou, Y., Tang, Y., et al. (2016). Compound K attenuates the development of atherosclerosis in ApoE(−/−) Mice via LXRalpha activation. International Journal of Molecular Sciences, 17(7), 1054. https://doi.org/10.3390/ijms17071054.
Lu, X. T., Liu, Y. F., Zhang, L., Yang, R. X., Liu, X. Q., Yan, F. F., et al. (2012). Unpredictable chronic mild stress promotes atherosclerosis in high cholesterol-fed rabbits. Psychosomatic Medicine, 74(6), 604–611. https://doi.org/10.1097/PSY.0b013e31825d0b71.
Okamoto, M., Irii, H., Yu, T., Ishii, H., Hirao, A., Udagawa, H., et al. (2011). Synthesis of a new [6]-gingerol analogue and its protective effect with respect to the development of metabolic syndrome in mice fed a high-fat diet. Journal of Medicinal Chemistry, 54(18), 6295.
Kumari, M., Grahame-Clarke, C., Shanks, N., Marmot, M., Lightman, S., & Vallance, P. (2003). Chronic stress accelerates atherosclerosis in the apolipoprotein E deficient mouse. Stress—The International Journal on the Biology of Stress, 6(4), 297–299.
Dimsdale, J. E. (2002). Psychological stress and cardiovascular disease. Journal of the American College of Cardiology, 325(7359), 337–338.
Willner, P. (1997). Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology (Berl), 134(4), 319–329.
Zhang, T., Chen, Y., Liu, H., Zhou, Z., Zhai, Y., & Yang, J. (2010). Chronic unpredictable stress accelerates atherosclerosis through promoting inflammation in apolipoprotein E knockout mice. Thrombosis Research, 126(5), 386.
Mao, Q. Q., Xian, Y. F., Ip, S. P., Tsai, S. H., & Che, C. T. (2010). Long-term treatment with peony glycosides reverses chronic unpredictable mild stress-induced depressive-like behavior via increasing expression of neurotrophins in rat brain. Behavioural Brain Research, 210(2), 171–177. https://doi.org/10.1016/j.bbr.2010.02.026.
Kumar, B., Kuhad, A., & Chopra, K. (2011). Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: Behavioral and biochemical evidences. Psychopharmacology (Berl), 214(4), 819–828. https://doi.org/10.1007/s00213-010-2094-2.
Thakare, V. N., Patil, R. R., Oswal, R. J., Dhakane, V. D., Aswar, M. K., & Patel, B. M. (2017). Therapeutic potential of silymarin in chronic unpredictable mild stress induced depressive-like behavior in mice. Journal of Psychopharmacology. https://doi.org/10.1177/0269881117742666.
Bruder-Nascimento, T., Campos, D. H., Alves, C., Thomaz, S., Cicogna, A. C., & Cordellini, S. (2013). Effects of chronic stress and high-fat diet on metabolic and nutritional parameters in Wistar rats. Arquivos Brasileiros de Endocrinologia e Metabologia, 57(8), 642–649.
Kurhe, Y., Radhakrishnan, M., & Gupta, D. (2014). Ondansetron attenuates depression co-morbid with obesity in obese mice subjected to chronic unpredictable mild stress; an approach using behavioral battery tests. Metabolic Brain Disease, 29(3), 701–710. https://doi.org/10.1007/s11011-014-9574-8.
Ren, Y., Wang, J. L., Zhang, X., Wang, H., Ye, Y., Song, L., et al. (2017). Antidepressant-like effects of ginsenoside Rg2 in a chronic mild stress model of depression. Brain Research Bulletin, 134, 211–219. https://doi.org/10.1016/j.brainresbull.2017.08.009.
Wu, T., Zhong, L., Hong, Z., Li, Y., Liu, X., Pan, L., et al. (2015). The effects of Zanthoxylum bungeanum extract on lipid metabolism induced by sterols. Journal of Pharmacological Sciences, 127(3), 251–259. https://doi.org/10.1016/j.jphs.2014.12.002.
Libby, P., Ridker, P. M., & Maseri, A. (2002). Inflammation and atherosclerosis. Circulation, 105(9), 1135–1143.
Akita, K., Isoda, K., Sato-Okabayashi, Y., Kadoguchi, T., Kitamura, K., Ohtomo, F., et al. (2017). An interleukin-6 receptor antibody suppresses atherosclerosis in atherogenic mice. Frontiers in Cardiovascular Medicine, 4, 84. https://doi.org/10.3389/fcvm.2017.00084.
Liu, Y. Z., Wang, Y. X., & Jiang, C. L. (2017). Inflammation: The common pathway of stress-related diseases. Frontiers in Human Neuroscience, 11, 316. https://doi.org/10.3389/fnhum.2017.00316.
Lu, X. T., Liu, Y. F., Zhao, L., Li, W. J., Yang, R. X., Yan, F. F., et al. (2013). Chronic psychological stress induces vascular inflammation in rabbits. Stress, 16(1), 87–98. https://doi.org/10.3109/10253890.2012.676696.
Branen, L., Hovgaard, L., Nitulescu, M., Bengtsson, E., Nilsson, J., & Jovinge, S. (2004). Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 24(11), 2137–2142. https://doi.org/10.1161/01.ATV.0000143933.20616.1b.
Li, Y., Xu, B., Xu, M., Chen, D., Xiong, Y., Lian, M., et al. (2017). 6-Gingerol protects intestinal barrier from ischemia/reperfusion-induced damage via inhibition of p38 MAPK to NF-kappaB signalling. Pharmacological Research, 119, 137–148. https://doi.org/10.1016/j.phrs.2017.01.026.
Algandaby, M. M., El-Halawany, A. M., Abdallah, H. M., Alahdal, A. M., Nagy, A. A., Ashour, O. M., et al. (2016). Gingerol protects against experimental liver fibrosis in rats via suppression of pro-inflammatory and profibrogenic mediators. Naunyn-Schmiedeberg’s Archives of Pharmacology, 389(4), 419–428. https://doi.org/10.1007/s00210-016-1210-1.
Nestel, P. J., Whyte, H. M., & Goodman, D. S. (1969). Distribution and turnover of cholesterol in humans. The Journal of Clinical Investigation, 48(6), 982–991. https://doi.org/10.1172/JCI106079.
Jeon, T. I., & Osborne, T. F. (2012). SREBPs: Metabolic integrators in physiology and metabolism. Trends in Endocrinology and Metabolism, 23(2), 65–72.
Ferré, P., & Foufelle, F. (2007). SREBP-1c transcription factor and lipid homeostasis: Clinical perspective. Hormone Research, 68(2), 72–82.
Miyata, S., Inoue, J., Shimizu, M., & Sato, R. (2015). Xanthohumol improves diet-induced obesity and fatty liver by suppressing sterol regulatory element-binding protein (SREBP) activation. The Journal of Biological Chemistry, 290(33), 20565–20579. https://doi.org/10.1074/jbc.M115.656975.
Cheon, S. Y., Chung, K. S., Lee, K. J., Choi, H. Y., Ham, I. H., Jung, D. H., et al. (2017). HVC1 ameliorates hyperlipidemia and inflammation in LDLR(−/−) mice. BMC Complementary and Alternative Medicine, 17(1), 222. https://doi.org/10.1186/s12906-017-1734-z.
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005). AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metabolism, 1(1), 15–25. https://doi.org/10.1016/j.cmet.2004.12.003.
Hardie, D. G. (2003). Minireview: the AMP-activated protein kinase cascade: The key sensor of cellular energy status. Endocrinology, 144(12), 5179–5183. https://doi.org/10.1210/en.2003-0982.
Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., et al. (2011). AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metabolism, 13(4), 376–388. https://doi.org/10.1016/j.cmet.2011.03.009.
Ejaz, A., Wu, D., Kwan, P., & Meydani, M. (2009). Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. The Journal of Nutrition, 139(5), 919–925. https://doi.org/10.3945/jn.108.100966.
Zhu, S., Wang, J., Zhang, Y., Li, V., Kong, J., He, J., et al. (2014). Unpredictable chronic mild stress induces anxiety and depression-like behaviors and inactivates AMP-activated protein kinase in mice. Brain Research, 1576, 81–90. https://doi.org/10.1016/j.brainres.2014.06.002.
Acknowledgements
This study was supported by a grant from the Second Special Foundation for National Traditional Chinese Medicine Clinical Research Base Construction of State Administration of Traditional Chinese Medicine (No. JDZX2015049).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Wang, S., Tian, M., Yang, R. et al. 6-Gingerol Ameliorates Behavioral Changes and Atherosclerotic Lesions in ApoE−/− Mice Exposed to Chronic Mild Stress. Cardiovasc Toxicol 18, 420–430 (2018). https://doi.org/10.1007/s12012-018-9452-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12012-018-9452-4